Increased serotonin-2 binding sites in frontal cortex of suicide victims.
D000328:Adult; D000929:Antidepressive Agents, Tricyclic / Q000494:pharmacology / Q000627:therapeutic use; D001665:Binding Sites; D002540:Cerebral Cortex / Q000378:metabolism*; D003866:Depressive Disorder / Q000188:drug therapy / Q000378:metabolism*; D005260:Female; D006801:Humans; D007488:Iprindole / Q000494:pharmacology / Q000627:therapeutic use; D008297:Male; D008995:Monoamine Oxidase / Q000494:pharmacology / Q000627:therapeutic use; D011985:Receptors, Serotonin / Q000187:drug effects / Q000378:metabolism*; D013405:Suicide
D000929:Antidepressive Agents, Tricyclic; D011985:Receptors, Serotonin; D007488:Iprindole; D008995:Monoamine Oxidase